Evidence map›Paper›PMID 33025172›Full record

ArticleWorld journal of microbiology & biotechnology2020

Effect of resveratrol and quercetin on the susceptibility of Escherichia coli to antibiotics.

Oleg N Oktyabrsky, Ksenia V Bezmaternykh, Galina V Smirnova, Alexey V Tyulenev

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Oleg N OktyabrskyLaboratory of Physiology and Genetics of Microorganisms, Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Russian Academy of Sciences, ul. Golev 13, 614081, Perm, Russia. oktyabr@iegm.ru.ORCID http://orcid.org/0000-0002-9864-209X
Ksenia V BezmaternykhLaboratory of Physiology and Genetics of Microorganisms, Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Russian Academy of Sciences, ul. Golev 13, 614081, Perm, Russia.
Galina V SmirnovaLaboratory of Physiology and Genetics of Microorganisms, Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Russian Academy of Sciences, ul. Golev 13, 614081, Perm, Russia.
Alexey V TyulenevLaboratory of Physiology and Genetics of Microorganisms, Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Russian Academy of Sciences, ul. Golev 13, 614081, Perm, Russia.
Institute of Ecology and Genetics of Microorganisms · RU

Funding

President of Russian Federation for young scientists MK-420-2020.4Russian Foundation of Basic Research (FRBR) 19-04-00888Russian Foundation of Basic Research (FRBR) 19-04-590009
6 · The paper itself

Abstract

Activities of plant polyphenols (PPs), resveratrol and quercetin, alone or in combination with four conventional antibiotics against Escherichia coli have been investigated. In medium without antibiotics, both polyphenols caused a dose-dependent growth inhibition. However, pretreatment with resveratrol (40 and 100 μg ml

Indexed as

Anti-Bacterial AgentsAntioxidantsbeta-GalactosidaseCefotaximeCiprofloxacinDrug Resistance, Multiple, BacterialEscherichia coliKanamycinOxidative StressPlant ExtractsPolyphenolsQuercetinResveratrolStreptomycinStress, PhysiologicalAnti-Bacterial AgentsAntioxidantsbeta-GalactosidaseCefotaximeCiprofloxacinKanamycinPlant ExtractsPolyphenolsQuercetinResveratrolStreptomycinAntibioticsEscherichia coliQuercetinResveratrol

Identifiers

PMID33025172
OpenAlexW3091783667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.